From clonal isolation to performance validation — accelerate your insect cell-based bioproduction and research.
We provide end-to-end development and screening of insect cell strains (including Sf9, Sf21, and Drosophila cell lines) for recombinant protein production, baculovirus expression, and functional genomic studies. Each project is designed around your target trait and throughput requirements.
Our integrated workflow combines clonal engineering, high-throughput screening, and rigorous quality control to deliver characterized insect cell strains with documented performance and stability.
Projects begin with the selection or engineering of your target insect cell line. We employ transfection, random mutagenesis, or directed evolution to introduce desired traits, followed by single-cell cloning to generate a panel of clonal candidates for screening.
Clone panels are screened for growth kinetics, productivity, and other relevant performance metrics using automated microplate assays. Hits are identified based on predefined thresholds and validated in repeat experiments.
Screening assays are tailored to your specific trait — whether it's recombinant protein yield, metabolic output, or resistance to culture stress. We design readouts that directly correlate with your downstream application.
Lead clones are cultured over multiple passages to assess genetic and phenotypic stability. Stable strains are cryopreserved as research cell banks with documented viability and identity.
Every step from cell sourcing to final bank is recorded, providing a transparent audit trail. Deliverables include a screening report, cell bank certificate, and recommended culture conditions.
Our standard package includes characterized cell lines, performance data, and quality documentation. Additional analytics can be scoped per project.
Each project is defined after consultation. The table below outlines common parameters; exact scope, clone numbers, and timeline are established in the project SOW.
| Parameter | Typical project scope |
|---|---|
| Target Host Cell Line | Sf9, Sf21, Schneider 2, or other insect cell lines; can be customer-supplied or sourced |
| Engineering Approach | Transfection (plasmid/viral), random mutagenesis (chemical/UV), or direct selection; type determined by project goals |
| Screening Readouts | Growth rate, viability, recombinant protein titer (ELISA/activity) |
| Number of Candidate Clones Screened | Scoped per project after consultation |
| Stability Passaging | Assessment over 10–20 passages; extended stability study available as add-on |
| Quality Control | Viability post-thaw, mycoplasma testing, genotype confirmation (PCR/sequencing) |
Our standardized process ensures consistent, documented delivery of characterized insect cell strains. Project-specific modifications are discussed during the initiation phase.
We obtain or receive your target insect cell line, review provenance, assess morphology and growth, and establish a baseline stock for subsequent engineering steps; molecular identity checks are defined separately in the scope. Initial quality checks include viability and mycoplasma testing.
Desired genetic modifications or selective pressures are applied (e.g., transfection, random mutagenesis). Single-cell cloning is performed via limiting dilution or FACS to generate a panel of clonal candidates for screening.
Clone panels are arrayed in microplates and assessed for growth kinetics, target expression, and other relevant traits using automated liquid handling and detection platforms. Multiple rounds of screening refine the hit list.
Lead clones are expanded into shake-flask or small bioreactor cultures for in-depth validation. Performance metrics are confirmed, and genotypic stability is assessed over several passages.
Validated clones are cryopreserved as research cell banks with documented viability and identity. A final report summarizing all screening data, stability results, and recommended culture conditions is delivered.
Our service supports a range of research and biomanufacturing needs where stable, high-performing insect cell lines are essential.
Develop insect cell strains optimized for maximal yield of recombinant proteins, including complex therapeutic glycoproteins and virus-like particles.
Create and screen permissive insect cell strains that support high-titer baculovirus stocks and robust recombinant protein output.
Generate reporter or engineered insect cell lines for compound screening, pathway studies, or target validation in Drosophila or other insect models.
Answers to typical questions regarding scope, timelines, and deliverables for insect cell strain development projects.
We routinely work with Sf9, Sf21, Hi5, and Drosophila Schneider 2 (S2) cells. Other insect lines (e.g., BTI-Tnao38, Ea4) can be accommodated on a case-by-case basis. The optimal host depends on your target trait and downstream application; we can advise during the project design phase.
Project timelines vary based on engineering approach, number of clones, and validation depth. As a general guide, from cell acquisition to cryopreservation of validated clones, projects typically range from 8 to 14 weeks. Exact timelines are confirmed in the project SOW.
We assess growth rate, viability, and target expression (if applicable) over a minimum of 10 passages. A stability report includes passage-wise trends, statistical analysis, and any observed drift. Extended stability studies over 20+ passages are available as an optional add-on.
Yes. Our screening infrastructure supports a wide array of readouts, including metabolic activity, reporter gene expression, cell size distribution, and resistance to stressors (e.g., temperature or pH).
Get a customized quote for your Custom Insect Cell Strain Development and Screening Services project. Our experts will respond within 24 hours.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.